In the aftermath of the global COVID-19 pandemic, there has been an urgent need to invest in new ways to diagnose and treat infectious diseases.
In the aftermath of the global COVID-19 pandemic, there has been an urgent need to invest in new ways to diagnose and treat infectious diseases. This has led to many different biotech R&D projects that strive both to further human understanding of viral infections at the molecular level and develop novel ways to detect and treat these infections.